http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20050084572-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_14727b82242af25381a728ea5833da6d |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-575 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J1-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-575 |
| filingDate | 2003-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba85d47a130a5f050f5854895c36b9f9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a03ceaf538c662a86a9d42d65cd396f4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c413282b211366f7350ef21d289b9f0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87c4efc961ba3651deaac8a7ebb16c83 |
| publicationDate | 2005-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20050084572-A |
| titleOfInvention | Derivatives comprising sterols and/or stanols and specific classes of anti-inflammatory agents and use thereof in treating or preventing cardiovascular disease |
| abstract | According to an aspect of the present invention there is provided a novel derivative comprising NSAIDs selected from salicylic acid and arylalkanoic acids, including sterols and / or stanols and salts of derivatives, and having at least one of the following formulas: a) R 2- (CH 2 ) n -CO-OR b) R 2 -R c) R 2 -CO-CO-OR d) Formula (I): , Wherein R is a sterol or stanol group, R 2 is derived from salicylic acid or arylalkanoic acid, n is 1-5. In addition, pharmaceutical compositions comprising one or more of the novel derivatives; And cardiovascular disease and atherosclerosis, hypercholesterolemia, hyperlipidemia, hypertension, thrombosis, coronary artery disease, comprising administering to the animal at least one of the compounds or biologically acceptable salts thereof, in a non-toxic and therapeutically effective amount. Treating or preventing basic symptoms of cardiovascular disease, including but not limited to, treating inflammation including coronary plaque inflammation, bacterial-induced inflammation, viral induced inflammation and inflammation associated with acute pain and surgical procedures, and A method for reducing is provided. |
| priorityDate | 2002-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.